Back
Summit Therapeutics Stock Price Chart

Your Summer Trading Shortcut
Try it free today.
Sell
39
SMMT
Summit Therapeutics
Last Price:
$22.66
Seasonality Move:
7.2%
7 Day Trial
ALL ACCESS PASS
$
7

Slow Market? Try This Instead
See how it works now.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMMT is experiencing slight buying pressure.
Summit Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.94 | Buy |
20-day SMA: | 20.56 | Buy |
50-day SMA: | 23.31 | Sell |
200-day SMA: | 21.04 | Buy |
8-day EMA: | 20.94 | Buy |
20-day EMA: | 21.13 | Buy |
50-day EMA: | 21.84 | Sell |
200-day EMA: | 19.45 | Buy |
Summit Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.44 | Sell |
Relative Strength Index (14 RSI): | 49.02 | Sell |
Chaikin Money Flow: | 35011 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.94 - 23.06) | Buy |
Bollinger Bands (100): | (18.55 - 24.97) | Sell |
Summit Therapeutics Technical Analysis
Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
17 | 18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Summit Therapeutics Stock
Is Summit Therapeutics Stock a Buy?
-
Summit Therapeutics share price is 21.20 while SMMT 8-day simple moving average is 20.94, which is a Buy signal.
-
The stock price of SMMT is 21.20 while Summit Therapeutics 20-day SMA is 20.56, which makes it a Buy.
-
Summit Therapeutics 50-day simple moving average is 23.31 while SMMT share price is 21.20, making it a Sell technically.
-
SMMT stock price is 21.20 and Summit Therapeutics 200-day simple moving average is 21.04, creating a Buy signal.
SMMT Technical Analysis vs Fundamental Analysis
Sell
39
Summit Therapeutics (SMMT)
is a Sell
Is Summit Therapeutics a Buy or a Sell?
-
Summit Therapeutics stock is rated a SellThe current Summit Therapeutics [SMMT] share price is $21.20. The Score for SMMT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Summit Therapeutics Stock Info
Market Cap:
15.7B
Price in USD:
21.20
Share Volume:
2.1M
Summit Therapeutics 52-Week Range
52-Week High:
36.91
52-Week Low:
6.78
Sell
39
Summit Therapeutics (SMMT)
is a Sell
Summit Therapeutics Share Price Forecast
-
What is the Summit Therapeutics stock price today?The Summit Therapeutics stock price is 21.20 USD today.
-
Will SMMT stock go up or go down?Summit Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Summit Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Summit Therapeutics is overvalued.
Is Summit Therapeutics Stock a Buy?
-
Summit Therapeutics share price is 21.20 while SMMT 8-day exponential moving average is 20.94, which is a Buy signal.
-
The stock price of SMMT is 21.20 while Summit Therapeutics 20-day EMA is 21.13, which makes it a Buy.
-
Summit Therapeutics 50-day exponential moving average is 21.84 while SMMT share price is 21.20, making it a Sell technically.
-
SMMT stock price is 21.20 and Summit Therapeutics 200-day simple moving average is 19.45, creating a Buy signal.
Fundamental Analysis of Summit Therapeutics
Is Summit Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.12 per share.
Technical Analysis of Summit Therapeutics
Should I short Summit Therapeutics stock?
-
SMMT Moving Average Covergence Divergence (MACD) indicator is -0.44, suggesting Summit Therapeutics is a Sell
-
Summit Therapeutics Relative Strength Index (RSI) is 49.02, which suggest Summit Therapeutics is oversold
-
The Bollinger Bands (25) for Summit Therapeutics is (18.94 - 23.06), which suggest Summit Therapeutics is a Sell
-
The Bollinger Bands (100) for Summit Therapeutics is (18.55 - 24.97), which suggest Summit Therapeutics is a Sell
* Summit Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.